Psychedelics

A New Era For Kratom: What The Latest FDA Study Reveals About Kratom Leaf
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA

Psychedelics Recent News

Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say
Psilocybin rivals antidepressants in treating depression while offering long-term well-being benefits, according to a new study.
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth
Bright Green Corporation addresses Nasdaq delisting, reinforces its commitment to shareholders, and outlines strategic partnerships and growth plans for the future.
Was Cannabis The Secret To Jesus' Healing Miracles? Study Uncovers Ancient Remedies
A study reveals the potential use of cannabis in biblical times, suggesting Jesus used it for healing and anointing practices.
Is Cannabis Legalization Reducing Psychiatric Drug Use? Study Reveals Interesting Trends In Benzodiazepine, Antidepressants, Antipsychotics
Cannabis legalization is reducing benzodiazepine use while increasing antidepressant and antipsychotic prescriptions, highlighting complex mental health impacts.
Scientists Gave LSD To Autistic Dogs: Mind-Blowing Brain Changes Deepened Connections With Humans
European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures
The PsychedeliCare initiative seeks 1 million signatures to push for an EU-wide legal framework for psychedelic-assisted therapies, targeting mental health needs.
Alabama Marijuana Company Sues Medical Cannabis Commission Over Licensing Chaos, Seeks Program Overhaul As Patients Remain In Limbo
Alabama Always files a lawsuit against the Alabama Medical Cannabis Commission, accusing it of procedural violations that have delayed the medical cannabis program for over a year.
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
A study finds that ultra-low-dose ketamine may reduce withdrawal symptoms, helping fentanyl users transition to buprenorphine treatment.
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Awakn Life Sciences expands its private placement to $2 million, closing the fourth tranche with $394,286 raised to accelerate research into addiction treatments.
DEA Endorses New, Simplified Test To Determine Marijuana's Medical Uses Amid Rescheduling Debate: Could It Also Apply To Psychedelics?
The DEA acknowledges a new two-part test for determining marijuana's accepted medical use, a significant shift as cannabis rescheduling efforts continue.
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
86% Of Drug Researchers Admit To Drug Use: NYU Study
NYU study reveals 86% of drug researchers have used substances, sparking debate over its impact on scientific objectivity.
Norwalk, CT's First Cannabis Dispensary Faces Solar Panel Dilemma: Tree Shade And Low ROI Hinder Compliance
Fine Fettle requests a waiver of Norwalk's solar panel requirement, citing feasibility and financial concerns at its Main St. cannabis dispensary location.